Barbara E. Lippok
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cytokine Signaling Pathways and Interactions
- Physiology top 5%
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 13
- PARP inhibition in cancer therapy 9
- Cytokine Signaling Pathways and Interactions 4
-
- Melanoma and MAPK Pathways 2
- Cell death mechanisms and regulation 2
- Co-authors
- Bernhard Lüscher (8 shared papers)Heike M. Hermanns (4 shared papers)Simone Radtke (4 shared papers)Peter C. Heinrich (4 shared papers)Patricia Verheugd (3 shared papers)Karla L. H. Feijs (3 shared papers)Mareike Bütepage (2 shared papers)Sarah Krieg (2 shared papers)
In The Last Decade
Barbara E. Lippok
12 papers receiving 492 citations
Peers
Comparison fields: 5 of 70
- Oncology 321
- Physiology 52
- Immunology 220
- Dermatology 46
- Infectious Diseases 54
Countries citing papers authored by Barbara E. Lippok
This map shows the geographic impact of Barbara E. Lippok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara E. Lippok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara E. Lippok more than expected).
Fields of papers citing papers by Barbara E. Lippok
This network shows the impact of papers produced by Barbara E. Lippok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara E. Lippok. The network helps show where Barbara E. Lippok may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara E. Lippok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 107 | |
| 2 | 2010 | 81 | |
| 3 | 2004 | 70 | |
| 4 | 2012 | 55 | |
| 5 | 2013 | 49 | |
| 6 | 2020 | 30 | |
| 7 | 2008 | 30 | |
| 8 | 2005 | 28 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 15 | |
| 11 | 2021 | 10 | |
| 12 | 2022 | 7 | |
| 13 | 2025 | 0 |
About Barbara E. Lippok
Barbara E. Lippok is a scholar working on Oncology, Molecular Biology, Immunology, Public Health, Environmental and Occupational Health and Physiology, having authored 13 papers that have together received 500 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Toxin Mechanisms and Immunotoxins (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Calcium signaling and nucleotide metabolism (2 papers), Melanoma and MAPK Pathways (2 papers), Cell death mechanisms and regulation (2 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Oncology (321 citations), Physiology (52 citations), Immunology (220 citations), Dermatology (46 citations) and Infectious Diseases (54 citations). Barbara E. Lippok has collaborated with scholars based in Germany, Finland and Italy. Frequent co-authors include Bernhard Lüscher, Heike M. Hermanns, Simone Radtke, Peter C. Heinrich, Patricia Verheugd, Karla L. H. Feijs, Mareike Bütepage, Sarah Krieg, Stefan Pflanz and Laura Eckei. Their work appears in journals such as European Journal of Medicinal Chemistry, Scientific Reports, Journal of Biological Chemistry, FEBS Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.